Identification of novel compounds against lower urinary tract symptoms and cystitis through docking and virtual screening Online publication date: Tue, 25-Jul-2017
by Balwant Kishan Malik; Rajni Jaiswal; Poonam Malik; Neha Malik; Uzma Khanam
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 10, No. 3, 2017
Abstract: Motivation: People suffering from infection in their urinary tract are more likely to get disease like cancer. Lower urinary tract symptom (LUTS) in male and Cystitis in female are common types of urinary tract infections. Drugs viz. alpha-blocker, 5-alpha-reductase inhibitors and antibiotics are used to treat these diseases. However, these drugs are also associated with adverse effects viz nausea etc. Therefore to overcome the adverse effects and to develop low-cost drugs, natural compounds need to be employed for target proteins. Result: The study was done with few novel proteins for LUTS and cystitis as targets and predicted their 3D structure using various tools. Predicted structures were validated and selected for the docking and virtual screening. Conclusion: Few natural promising compounds were identified in the study for further drug development.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook